Johnson & Johnson, U.S. agree on drug discounts, new plants
Key Terms
tariffs
regulatory
Tariffs are taxes imposed by a government on goods…
STAT staffers share stories they wish they had written in 2025
This year saw upheaval in all corners of health, science, and biotech. While our staff was covering all…
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
Launch prices for new drugs ‘significantly’ exceed inflation, analysis says
Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
Patient groups cheer as the WHO adds diabetes and cystic fibrosis drugs to its essential medicines list
For the first time, the World Health Organization has added various high-cost treatments for diabetes and cystic fibrosis…